Mutational definition of the human immunodeficiency virus type 1 Rev activation domain
- PMID: 2072452
- PMCID: PMC248862
- DOI: 10.1128/JVI.65.8.4248-4254.1991
Mutational definition of the human immunodeficiency virus type 1 Rev activation domain
Abstract
Replication of human immunodeficiency virus type 1 requires the functional expression of the virally encoded Rev protein. The binding of this nuclear trans activator to its viral target sequence, the Rev-response element, induces the cytoplasmic expression of unspliced viral mRNAs. Mutation of the activation domain of Rev generates inactive proteins with normal RNA binding capabilities that inhibit wild-type Rev function in a trans-dominant manner. Here, we report that the activation domain comprises a minimum of nine amino acids, four of which are critically spaced leucines. The preservation of this essential sequence in other primate and nonprimate lentivirus Rev proteins indicates that this leucine-rich motif has been highly conserved during evolution. This conclusion, taken together with the observed permissiveness of a variety of eukaryotic cell types for Rev function, suggests that the target for the activation domain of Rev is likely to be a highly conserved cellular protein(s) intrinsic to nuclear mRNA transport or splicing.
Similar articles
-
Human immunodeficiency virus type 1 Rev activation can be achieved without Rev-responsive element RNA if Rev is directed to the target as a Rev/MS2 fusion protein which tethers the MS2 operator RNA.J Virol. 1992 Dec;66(12):7469-80. doi: 10.1128/JVI.66.12.7469-7480.1992. J Virol. 1992. PMID: 1433526 Free PMC article.
-
Functional analysis of interactions between Tat and the trans-activation response element of human immunodeficiency virus type 1 in cells.J Virol. 1993 Sep;67(9):5617-22. doi: 10.1128/JVI.67.9.5617-5622.1993. J Virol. 1993. PMID: 8350414 Free PMC article.
-
Co-expression of a trans-dominant negative mutant of the human immunodeficiency virus type 1 (HIV-1) Rev protein affects the Rev-dependent splicing pattern and expression of HIV-1 RNAs.J Gen Virol. 1999 Aug;80 ( Pt 8):1965-1974. doi: 10.1099/0022-1317-80-8-1965. J Gen Virol. 1999. PMID: 10466792
-
Rev-dependent expression of three species of HIV-1 mRNAs (review).Int J Mol Med. 1999 Mar;3(3):297-302. doi: 10.3892/ijmm.3.3.297. Int J Mol Med. 1999. PMID: 10028055 Review.
-
The HIV-1 Rev protein.Annu Rev Microbiol. 1998;52:491-532. doi: 10.1146/annurev.micro.52.1.491. Annu Rev Microbiol. 1998. PMID: 9891806 Review.
Cited by
-
A mutant Tat protein provides strong protection from HIV-1 infection in human CD4+ T cells.Hum Gene Ther. 2013 Mar;24(3):270-82. doi: 10.1089/hum.2012.176. Epub 2013 Mar 1. Hum Gene Ther. 2013. PMID: 23298160 Free PMC article.
-
Influenza B and C virus NEP (NS2) proteins possess nuclear export activities.J Virol. 2001 Aug;75(16):7375-83. doi: 10.1128/JVI.75.16.7375-7383.2001. J Virol. 2001. PMID: 11462009 Free PMC article.
-
Inhibition of human immunodeficiency virus Rev and human T-cell leukemia virus Rex function, but not Mason-Pfizer monkey virus constitutive transport element activity, by a mutant human nucleoporin targeted to Crm1.J Virol. 1998 Nov;72(11):8627-35. doi: 10.1128/JVI.72.11.8627-8635.1998. J Virol. 1998. PMID: 9765402 Free PMC article.
-
Multimer formation is not essential for nuclear export of human T-cell leukemia virus type 1 Rex trans-activator protein.J Virol. 1998 Nov;72(11):8659-68. doi: 10.1128/JVI.72.11.8659-8668.1998. J Virol. 1998. PMID: 9765406 Free PMC article.
-
Nonviral and viral delivery of a human immunodeficiency virus protective gene into primary human T cells.Proc Natl Acad Sci U S A. 1994 Nov 22;91(24):11581-5. doi: 10.1073/pnas.91.24.11581. Proc Natl Acad Sci U S A. 1994. PMID: 7972106 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
